Fig. 3From: Long term follow-up of neoadjuvant chemotherapy for non-small cell lung cancer (NSCLC) investigating early positron emission tomography (PET) scan as a predictor of outcomeKaplan-Meier progression free survival curve, stratified by metabolic response on interval FDGPET imaging. Response was defined as ≥20% decrease in SUV of the dominant lesionBack to article page